Drug Trial Radar · NCT06134492
Acyclovir in Ventilated Patients With Pneumonia and HSV-1 in BAL
Last checked: Nov 20, 2026Latest source record: Jul 23, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Recruiting
Enrollment
616
Planned (sponsor's estimate)
Start
Feb 20, 2024
Primary completion
Jul 2026
Study completion Dec 2026
Sponsor
- Lead sponsor
- Jena University HospitalAcademic, hospital or other
- Sponsor type
- Academic, hospital or other
- First posted
- Nov 18, 2023
Design
- Study type
- Interventional
- Phase
- Phase 3
- Allocation
- Randomized
- Model
- Parallel
- Masking
- None
- Primary purpose
- Treatment
- FDA-regulated drug
- No
- Who can join
- All sexes, from 18 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
Almost 90 out of 100 people carry herpes simplex viruses (HSV). Once a person has been infected with the herpes viruses, he or she can't get rid of them for the rest of her/his life. For the most part, the viruses are in a dormant state. Only when the immune system is weakened, for example in the case of a serious illness or stress, are the viruses reactivated. They then mainly cause cold sores, which are harmless for healthy people and usually heal without therapy. However, especially in people with a weakened immune system, HSV can also cause serious infections, such as meningitis. In almost every second mechanically ventilated patient in intensive care who has pneumonia, HSV can be detected in the respiratory tract. This is caused by reactivation of the viruses as a result of the severe underlying disease and stress during intensive care therapy. Whether treatment of the herpes viruses (e.g. with acyclovir) is necessary in this situation and helps the patients to cure has not been clarified, especially as acyclovir can also cause side effects such as a deterioration in kidney function. Currently, the physicians decide to treat the herpes viruses in about half of the patients. Several studies have shown that patients for whom the physician decided to treat the viruses survived more often. However, all of these studies looked at the course of the disease only retrospectively and thus are subject to many biases (including physician selection of who receives treatment, missing data). A definitive conclusion as to whether herpesvirus therapy can be recommended cannot be drawn without doubt from these studies. Therefore, the investigators would like to investigate in a randomized controlled trial, i.e. patients are randomly assigned to the experimental (therapy of herpesviruses) or control group (no therapy of herpesviruses), the effect of therapy with acyclovir on survival in ventilated intensive care patients with lower respiratory tract infection (pneumonia) in whom a large amount of HSV was found in the respiratory tract. The goal of the study is to provide clarity on whether therapy will help patients recover.
Conditions
- Pneumonia, Viral
- Ventilator Associated Pneumonia
- Community-acquired Pneumonia
- Herpes Simplex
- Hospital-acquired Pneumonia
Interventions
AcyclovirDrug
Dosage: 10mg/kg (current) body weight every 8 hours, dose adjustment to renal function according to technical information. Mode of administration: intravenous (i.v.)
Primary outcomes
What the sponsor says the trial is designed to measure.
- mortality (survival status)Time frame: day 30
Locations
28 sites in 1 country. Site status is shown where the registry gives one.
Evangelisches Klinikum Bethel
Bielefeld, Germany · Recruiting
Universitätsklinikum Freiburg
Freiburg im Breisgau, Baden-Wurttemberg, Germany · Recruiting
Universitätsklinikum Heidelberg
Heidelberg, Baden-Wurttemberg, Germany · Recruiting
Universitätsklinikum Heidelberg
Heidelberg, Baden-Wurttemberg, Germany · Recruiting
Universitätsklinikum Tübingen
Tübingen, Baden-Wurttemberg, Germany · Recruiting
Universitätsklinikum Augsburg
Augsburg, Bavaria, Germany · Recruiting
Klinikum der Ludwig-Maximilian-Universität München
München, Bavaria, Germany · Recruiting
Klinikum rechts der Isar
München, Bavaria, Germany · Recruiting
Klinikum rechts der Isar
München, Bavaria, Germany · Recruiting
Klinikum Nürnberg, Campus Nord
Nuremberg, Bavaria, Germany · Recruiting
Klinikum Nürnberg, Campus Süd
Nuremberg, Bavaria, Germany · Recruiting
Universitätsklinikum Regensburg
Regensburg, Bavaria, Germany · Recruiting
RoMed Klinikum Rosenheim
Rosenheim, Bavaria, Germany · Recruiting
Universitätsklinikum Hamburg Eppendorf
Hamburg, Free and Hanseatic City of Hamburg, Germany · Recruiting
Marien Hospital Herne, Universitätsklinikum der Ruhr-Universität Bochum
Herne, Nordreihn-Westfalen, Germany · Recruiting
Evangelisches Klinikum Bethel
Bielefeld, North Rhine-Westphalia, Germany · Recruiting
Universitätsklinikum Bonn
Bonn, North Rhine-Westphalia, Germany · Recruiting
Universitätsklinikum Köln AöR
Cologne, North Rhine-Westphalia, Germany · Recruiting
Universitätsklinikum Düsseldorf
Düsseldorf, North Rhine-Westphalia, Germany · Recruiting
Universitätsklinikum Essen
Essen, North Rhine-Westphalia, Germany · Recruiting
Universitätsklinikum Münster
Münster, North Rhine-Westphalia, Germany · Recruiting
Universitätsklinikum Dresden
Dresden, Saxony, Germany · Recruiting
Universitätsklinikum Leipzig
Leipzig, Saxony, Germany · Recruiting
Universitätsklinikum Leipzig
Leipzig, Saxony, Germany · Recruiting
Universitätsklinikum Halle
Halle, Saxony-Anhalt, Germany · Recruiting
Universitätsklinikum Schleswig-Holstein Campus Kiel
Kiel, Schleswig-Holstein, Germany · Recruiting
Universitätsklinikum Schleswig-Holstein Campus Lübeck
Lübeck, Schleswig-Holstein, Germany · Recruiting
Universitätsklinikum Jena
Jena, Thuringia, Germany · Recruiting
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.